Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
HROW
#1670
Harrow, Inc. Common Stock
54.180
0
+4.66%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+4.66%
Changement Mensuel
+25.82%
Evolution sur 6 mois
+38.92%
Changement Annuel
+38.92%
Clôture Précédente
51.770
0
Open
54.180
0
Bid
Ask
Low
54.180
0
High
54.180
0
Volume
56
Marchés
Actions des Marchés US
Soins de Santé
HROW
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Nouvelles
These Growth Stocks Form Classic Cup Bases. Here's Where To Buy.
Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More
Esperion Therapeutics (ESPR) Earnings Expected to Grow: Should You Buy?
Analysts Boost Profit Forecasts On Two Names. One Is A Data Center Play.
Why IBD Stock Of The Day Harrow Has Its Sights On A Breakout
Harrow (HROW) Reports Next Week: Wall Street Expects Earnings Growth
These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks
Aerospace/Defense Play Karmen Leads 19 To Best Stock Lists Including IBD 50, Stock Spotlight
Halozyme, Other Hot Medical Plays Lead 22 Stocks Onto Best Stock Lists Like IBD 50, IPO Leaders
Eye Care Stock Sees New Path After Guidance
B.Riley réitère sa recommandation d’achat sur Harrow Health avec la croissance de VEVYE
B.Riley reiterates Buy rating on Harrow Health stock amid VEVYE growth